Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis
Positive allosteric modulators (PAMs) of AMPA receptors represent attractive candidates for the development of drugs for the treatment of cognitive and neurodegenerative disorders. Dimeric molecules have been reported to have an especially potent modulating effect, due to the U-shaped form of the AM...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/23/8252 |
_version_ | 1797462625173372928 |
---|---|
author | Kseniya N. Sedenkova Denis V. Zverev Anna A. Nazarova Mstislav I. Lavrov Eugene V. Radchenko Yuri K. Grishin Alexey V. Gabrel’yan Vladimir L. Zamoyski Vladimir V. Grigoriev Elena B. Averina Vladimir A. Palyulin |
author_facet | Kseniya N. Sedenkova Denis V. Zverev Anna A. Nazarova Mstislav I. Lavrov Eugene V. Radchenko Yuri K. Grishin Alexey V. Gabrel’yan Vladimir L. Zamoyski Vladimir V. Grigoriev Elena B. Averina Vladimir A. Palyulin |
author_sort | Kseniya N. Sedenkova |
collection | DOAJ |
description | Positive allosteric modulators (PAMs) of AMPA receptors represent attractive candidates for the development of drugs for the treatment of cognitive and neurodegenerative disorders. Dimeric molecules have been reported to have an especially potent modulating effect, due to the U-shaped form of the AMPA receptor’s allosteric binding site. In the present work, novel bis(pyrimidines) were studied as AMPA receptor modulators. A convenient and flexible preparative approach to bis(pyrimidines) containing a hydroquinone linker was elaborated, and a series of derivatives with varied substituents was obtained. The compounds were examined in the patch clamp experiments for their influence on the kainate-induced currents, and 10 of them were found to have potentiating properties. The best potency was found for 2-methyl-4-(4-((2-methyl-5,6,7,8-tetrahydroquinazolin-4-yl)oxy)phenoxy)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>d</i>]pyrimidine, which potentiated the kainate-induced currents by up to 77% in all tested concentrations (10<sup>−12</sup>–10<sup>−6</sup> M). The results were rationalized via the modeling of modulator complexes with the dimeric ligand binding domain of the GluA2 AMPA receptor, using molecular docking and molecular dynamics simulation. The prediction of ADMET, physicochemical, and PAINS properties of the studied bis(pyrimidines) confirmed that PAMs of this type may act as the potential lead compounds for the development of neuroprotective drugs. |
first_indexed | 2024-03-09T17:39:16Z |
format | Article |
id | doaj.art-0407b9018059428e84eb2f481bc3d013 |
institution | Directory Open Access Journal |
issn | 1420-3049 |
language | English |
last_indexed | 2024-03-09T17:39:16Z |
publishDate | 2022-11-01 |
publisher | MDPI AG |
record_format | Article |
series | Molecules |
spelling | doaj.art-0407b9018059428e84eb2f481bc3d0132023-11-24T11:39:07ZengMDPI AGMolecules1420-30492022-11-012723825210.3390/molecules27238252Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR AnalysisKseniya N. Sedenkova0Denis V. Zverev1Anna A. Nazarova2Mstislav I. Lavrov3Eugene V. Radchenko4Yuri K. Grishin5Alexey V. Gabrel’yan6Vladimir L. Zamoyski7Vladimir V. Grigoriev8Elena B. Averina9Vladimir A. Palyulin10Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaInstitute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Severny proezd 1, Chernogolovka, 142432 Moscow, RussiaInstitute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Severny proezd 1, Chernogolovka, 142432 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaPositive allosteric modulators (PAMs) of AMPA receptors represent attractive candidates for the development of drugs for the treatment of cognitive and neurodegenerative disorders. Dimeric molecules have been reported to have an especially potent modulating effect, due to the U-shaped form of the AMPA receptor’s allosteric binding site. In the present work, novel bis(pyrimidines) were studied as AMPA receptor modulators. A convenient and flexible preparative approach to bis(pyrimidines) containing a hydroquinone linker was elaborated, and a series of derivatives with varied substituents was obtained. The compounds were examined in the patch clamp experiments for their influence on the kainate-induced currents, and 10 of them were found to have potentiating properties. The best potency was found for 2-methyl-4-(4-((2-methyl-5,6,7,8-tetrahydroquinazolin-4-yl)oxy)phenoxy)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>d</i>]pyrimidine, which potentiated the kainate-induced currents by up to 77% in all tested concentrations (10<sup>−12</sup>–10<sup>−6</sup> M). The results were rationalized via the modeling of modulator complexes with the dimeric ligand binding domain of the GluA2 AMPA receptor, using molecular docking and molecular dynamics simulation. The prediction of ADMET, physicochemical, and PAINS properties of the studied bis(pyrimidines) confirmed that PAMs of this type may act as the potential lead compounds for the development of neuroprotective drugs.https://www.mdpi.com/1420-3049/27/23/8252pyrimidinesS<sub>N</sub>Ar reactionsbis(pyrimidine)bivalent ligandionotropic glutamate receptorsAMPA receptor |
spellingShingle | Kseniya N. Sedenkova Denis V. Zverev Anna A. Nazarova Mstislav I. Lavrov Eugene V. Radchenko Yuri K. Grishin Alexey V. Gabrel’yan Vladimir L. Zamoyski Vladimir V. Grigoriev Elena B. Averina Vladimir A. Palyulin Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis Molecules pyrimidines S<sub>N</sub>Ar reactions bis(pyrimidine) bivalent ligand ionotropic glutamate receptors AMPA receptor |
title | Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis |
title_full | Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis |
title_fullStr | Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis |
title_full_unstemmed | Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis |
title_short | Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis |
title_sort | novel nanomolar allosteric modulators of ampa receptor of bis pyrimidine series synthesis biotesting and sar analysis |
topic | pyrimidines S<sub>N</sub>Ar reactions bis(pyrimidine) bivalent ligand ionotropic glutamate receptors AMPA receptor |
url | https://www.mdpi.com/1420-3049/27/23/8252 |
work_keys_str_mv | AT kseniyansedenkova novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis AT denisvzverev novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis AT annaanazarova novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis AT mstislavilavrov novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis AT eugenevradchenko novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis AT yurikgrishin novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis AT alexeyvgabrelyan novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis AT vladimirlzamoyski novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis AT vladimirvgrigoriev novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis AT elenabaverina novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis AT vladimirapalyulin novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis |